Grade My Investments
Home › Free Stock Grades › LMRI

Lumexa Imaging Holdings, Inc. Common Stock (LMRI) Stock Grade

LMRI · Healthcare

C
Grade updated: September 29, 2026
Computed by the GradeMyInvestments scoring model from revenue growth, profitability, balance-sheet strength, and analyst targets.
Market Cap
$974.7M
P/E Ratio
—
Revenue Growth (YoY)
+7.8%
Net Margin
-4.6%
Return on Equity
—
Dividend Yield
None

About Lumexa Imaging Holdings, Inc. Common Stock's fundamentals

Lumexa Imaging Holdings is a medical device company with a market capitalization of $974.7 million that generated 7.8% year-over-year revenue growth in its latest reporting period. Despite growing revenues, the company reported a net loss with a negative net margin of -4.6%, indicating it is not yet profitable. The company does not pay a dividend and lacks sufficient earnings to calculate traditional profitability metrics like P/E ratio and return on equity.

Track LMRI free — no credit card required. Live grade + monthly AI report →